Search Orphan Drug Designations and Approvals
-
Generic Name: | Tiratricol |
---|---|
Date Designated: | 08/13/1991 |
Orphan Designation: | For use in combination with levo-thyroxine to suppress thyroid stimulating hormone in patients with well-differentiated thyroid cancer who are intolerant to adequate doses of levo-thyroxine alone. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Laphal Laboratoires 48 Bis, Rue des Belles-Feuilles Paris France The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-